Cargando…
Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(−1)
Percent free prostatic-specific antigen (%fPSA) has been introduced as a tool to avoid unnecessary biopsies in patients with a serum PSA level of 4.0–10.0 ng ml(−1), however, it remains controversial whether %fPSA is effective in PSA range of 10.1–20.0 ng ml(−1) in both Chinese and Western populatio...
Autores principales: | Chen, Rui, Zhou, Li-Qun, Cai, Xiao-Bing, Xie, Li-Ping, Huang, Yi-Ran, He, Da-Lin, Gao, Xu, Xu, Chuan-Liang, Ding, Qiang, Wei, Qiang, Yin, Chang-Jun, Ren, Shan-Cheng, Wang, Fu-Bo, Tian, Ye, Sun, Zhong-Quan, Fu, Qiang, Ma, Lu-Lin, Zheng, Jun-Hua, Ye, Zhang-Qun, Ye, Ding-Wei, Xu, Dan-Feng, Hou, Jian-Quan, Xu, Ke-Xin, Yuan, Jian-Lin, Gao, Xin, Liu, Chun-Xiao, Pan, Tie-Jun, Sun, Ying-Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814972/ https://www.ncbi.nlm.nih.gov/pubmed/25926603 http://dx.doi.org/10.4103/1008-682X.150846 |
Ejemplares similares
-
Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0–10.0 ng/ml
por: Chen, Rui, et al.
Publicado: (2015) -
Percent free prostate-specific antigen for prostate cancer diagnosis in Chinese men with a PSA of 4.0–10.0 ng/mL: Results from the Chinese Prostate Cancer Consortium
por: Chen, Rui, et al.
Publicado: (2015) -
Evaluation of the Prostate Imaging Reporting and Data System for Magnetic Resonance Imaging Diagnosis of Prostate Cancer in Patients with Prostate-specific Antigen <20 ng/ml
por: Wang, Xuan, et al.
Publicado: (2016) -
Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis
por: Kan, Hung-Cheng, et al.
Publicado: (2017) -
Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
por: LIU, Xin, et al.
Publicado: (2015)